Menu Search Icon

Search

Department of Pharmacology

Pharmacology is a broad and integrative discipline that focuses on the interaction of living cells with the regulatory molecules in their environment. It is a diverse science that proves basic mechanisms of molecular and cellular function with the knowledge that unraveling these mechanisms will lead to new therapeutic approaches to a variety of diseases. The Department of Pharmacology has a unique role within the basic biomedical sciences: to conduct investigations into the fundamental principles of cell function and translate these findings to clinical applications.

Our faculty offer a variety of exciting research opportunities in Cellular and Molecular Pharmacology, including the following Research Interests:

  • Cardiovascular/Respiratory Biology
  • Cellular Physiology
  • Chemical Biology and Molecular Pharmacology
  • Immunity and Inflammation
  • Metabolism
  • Molecular and Systems Neuroscience

 

Doug Bayliss and Yingtang Shi

Doug Bayliss, PhD, and Yingtang Shi, MD, Awarded $3 Million to Study Phox2b-Regulated Genes That Impact Breathing

Doug Bayliss, PhD, the Joseph & Frances Larner Professor and chair of the Department of Pharmacology, and Yingtang Shi, MD, an assistant professor of research in the Department of Pharmacology, were awarded a new $3 million grant from the National Heart Lung and Blood Institute, titled “Molecular physiology of Phox2b-expressing RTN chemoreceptor neurons.”

Read More

Jewelle Sanchez

Beenhakker Lab Student, Jewelle Sanchez, Receives 2025 Harrison Undergraduate Research Award

Congratulations to Jewelle Sanchez on her receipt of the 2025 Harrison Undergraduate Research Award!

Read More

Qi-Ling Labs

Ling Qi, PhD, and Shengyi Iris Sun, PhD, Earn $3.2 Million to Research Protein Degradation in the Endoplasmic Reticulum

Congratulations to Ling Qi, PhD, professor and chair of the Department of Molecular Physiology and Biological Physics, and Shengyi (Iris) Sun, PhD, associate professor in the Department of Pharmacology, and their research teams on their receipt of a $3.2 million grant from the National Institute of Neurological Disorders and Stroke (NINDS) to investigate the mechanisms underlying SEL1L-HRD1 ERAD (Endoplasmic Reticulum-Associated Degradation) disease variants.

Read more

Explore the UVA BIMS Program

Our distinguished faculty and cutting-edge curriculum empower future leaders in biomedical research to tackle today's complex challenges with passion and expertise.

Our deadline for Fall 2024 admission was December 1, 2023, and applications are currently under review. The application portal will open on September 1, 2024, for Fall 2025 admission.

More Information

News All News »

Doug Bayliss, PhD, and Yingtang Shi, MD, Awarded $3 Million to Study Phox2b-Regulated Genes That Impact Breathing

Doug Bayliss, PhD, the Joseph & Frances Larner Professor and chair of the Department of Pharmacology, and Yingtang Shi, MD, an assistant professor of research in the Department of Pharmacology,…

Ling Qi, PhD, and Shengyi Iris Sun, PhD, Earn $3.2 Million to Research Protein Degradation in the Endoplasmic Reticulum

Ling Qi, PhD, professor and chair of the Department of Molecular Physiology and Biological Physics, and Shengyi (Iris) Sun, PhD, associate professor in the Department of Pharmacology, and their research…

Beenhakker Lab Student, Jewelle Sanchez, Receives 2025 Harrison Undergraduate Research Award

Congratulations to Jewelle Sanchez on her receipt of the 2025 Harrison Undergraduate Research Award! Made possible through the generosity of the late David A. Harrison, III and his family, the…

Perez-Reyes Lab Student, Amir Behrooz, Receives 2025 Harrison Undergraduate Research Award

Congratulations to Amir Behrooz on his receipt of the 2025 Harrison Undergraduate Research Award! Made possible through the generosity of the late David A. Harrison, III and his family, the…

Seminars All Seminars »

Pharmacology Seminar: Jeff Sturek, MD, PhD

[Pinn Hall 5023] B Cells and Antibodies in Lung Injury and Repair
May
1